Social Determinants of Health Impact Cervical Cancer Stage at Presentation among Women in Zambia
Graciela M. Nogueras Gonzalez, Mehmet Enes Inam, Susan Msadabwe, Kamaria L Lee, Bernadette Njala, Dyness Sakala, Mwando Chitula, Jane R Montealegre, Susan Peterson, Elizabeth Chiao, Lilie L. Lin

TL;DR
This study explores how social factors, like awareness of cervical cancer risks, affect the stage at which women in Zambia are diagnosed with cervical cancer.
Contribution
The study identifies lack of awareness about cervical cancer risks and symptoms as a novel factor associated with advanced cancer stage at presentation in Zambia.
Findings
Lack of knowledge about cervical cancer risks and symptoms was significantly associated with advanced cancer stage (OR = 1.79).
Standard social determinants like education and housing were not linked to advanced cancer stage.
Improving awareness through education could reduce late-stage cervical cancer presentations.
Abstract
The impact of social determinants of health (SDOH) on cervical cancer stage in Zambia remains poorly understood and understudied. We administered the Accountable Health Communities Health-Related Social Needs Screening Tool, modified for Zambian culture, to newly diagnosed cervical cancer patients at the Cancer Diseases Hospital (CDH) in Lusaka, Zambia. The primary aim of the study was to determine the relationship between sociodemographic factors, SDOH domains, and advanced cervical cancer stage (III/IV) at presentation to CDH. Logistic regression models were performed to determine associations. Between June 2022 and March 2025, there were 259 survey respondents. Their median age was 50 years (range: 29–78), 47.1% of them were diagnosed with advanced cervical cancer, 55.2% were women living with HIV, and most (92.6%) had completed primary or secondary education. Although none of the…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —NCI
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCervical Cancer and HPV Research · Global Cancer Incidence and Screening · Endometrial and Cervical Cancer Treatments
INTRODUCTION
Social determinants of health (SDOH) encompass non-medical factors that impact patient health, including marital status, educational level, neighborhood disadvantage, social support, income status, and patient health literacy.^1^ SDOH factors have been linked to obstacles in accessing timely care for cancer patients, resulting in advanced-stage diagnoses and poorer outcomes. Impacts of SDOH on cancer outcomes, including late stage of diagnosis have been documented in well-developed countries such as the U.K. and Australia.^2–4^
Cervical cancer is one of the most preventable and treatable cancers, but remains a significant global health burden.^5^ In low- and middle-income countries (LMICs) like Zambia, the impact of SDOH, including healthcare access barriers, including health literacy is even more pronounced.^6–8^ In Zambia as in other countries in Southern Africa, cervical cancer remains the leading cause of cancer incidence and mortality.^9^ Healthcare access barriers may contribute to lengthy delays in diagnosis and treatment, highlighting the urgent need for targeted research and policy interventions that enhance cancer care delivery in resource-limited settings.^10–12^
Research on SDOH and cervical cancer in LMICs like Zambia remains limited. This study aims to understand the relationship between SDOH domains and advanced cervical cancer stage, defined as stage III/IV based on the International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging system, at presentation to the Cancer Diseases Hospital (CDH) in Lusaka, the only oncology hospital in Zambia. Women presenting for care for newly diagnosed cervical cancer at CDH were approached for enrollment in this cross-sectional study. They completed a culturally adapted health-related social needs survey, the Accountable Health Communities (AHC) Health-Related Social Needs (HRSN) Screening Tool.^1^ The long-term goal of our study was to understand the relationship of multi-level SDOH domains with advanced-stage cervical cancer at diagnosis.
METHODS
We conducted an observational, cross-sectional study using a survey adapted from the AHC HRSN Screening Tool developed by the US Centers for Medicare & Medicaid Services.^13–16^ The survey assessed SDOH domains, including the core domains of housing instability, food insecurity, transportation problems, and utility assistance needs, but omitted the interpersonal safety questions to tailor the survey to Zambia’s cultural and ethical context. Questions in the supplemental domain of the HRSN screening tool were also included, such as questions on financial strain, employment, education, physical activity, family and community support, health behaviors or substance use, health literacy and knowledge about cervical cancer, and disabilities. The survey was translated into the 4 most common Zambian languages (Tonga, Nyanga, Lozi, and Bemba).
Patients 18 or older with newly diagnosed cervical cancer who presented for treatment at CDH between June 2022 and March 2025 were approached for participation. After obtaining consent, data were collected through an in-person interview. Each interview lasted approximately 25–35 minutes. The survey was administered in person by a research coordinator and in the patient’s preferred language. A research electronic data capture project (REDCap) database was designed for patient-reported data registration.^17,18^ The study was approved by the University of Zambia’s Biomedical Ethics Research Committee and The University of Texas MD Anderson Cancer Center’s Institutional Review Board.
Statistical Methods
The primary endpoint of the study was cancer stage at presentation, defined as cancer of the cervix uteri of 2018 FIGO stage III/IV.^19–21^ Descriptive statistics were used to summarize the characteristics of the study population overall and by cancer stage at presentation. Chi-square or Fisher exact tests were performed as appropriate for categorical variables, and Wilcoxon rank-sum tests for continuous variables. A p < 0.05 was considered statistically significant.
Logistic regression models examined the associations between advanced cancer stage and SDOH domains. Sociodemographic variables were also explored in the logistic regression models. For the adjusted logistic regression model, we included variables from the unadjusted logistic regression models with an alpha level less than 0.10. Any variable with missing values greater than or equal to 25% were excluded for the adjusted model. All analyses were conducted using Stata/MP 18.0 for Windows (College Station, Texas).
RESULTS
Between June 2022 and March 2025, 259 patients completed the survey, and 47.1% of them had advanced-stage disease (FIGO stage III/IV). The respondents’ median age was 50 years (range: 29–78), and most patients (79.1%) had completed primary or secondary education (analogous to elementary school or high school in the U.S.), 13.6% had no education, and only 7.4% had completed tertiary education, as reported in Table 1. More than half (55.4%) lived in urban areas (in a town). Patients traveled to CDH from all provinces of Zambia, but mainly were from Lusaka (29.3%), the Copperbelt (17.8%), and the Southern (16.2%), Eastern (13.5%), and Central (11.2%) provinces. The remaining five Zambian provinces each contributed less than 3% of the participating patients. Of the 259 patients surveyed, 143 (55.2%) were women living with human immunodeficiency virus (WLHIV), only 38.8% had prior cervical cancer screening, and 34.4% reported having prior knowledge about their cervical cancer risks and symptoms. There were no significant differences in sociodemographic factors and HIV status between patients with advanced and early FIGO stages. However, some marginally significant differences were found in education and residency. The percentage of early-stage cancer patients with tertiary education was higher than that among patients with less education (10.3% vs. 4.1%; p = 0.057), and a greater proportion of early-stage patients lived in urban areas than in rural areas (61.0% vs. 41.2%; p = 0.056). Patients diagnosed with early-stage disease were significantly more knowledgeable about their cervical cancer risks and symptoms than were advanced-stage patients (41.6% vs. 26.2%, p = 0.009). Among the SDOH domains, early-stage disease patients reported cooking outside or in a building separate from the house significantly less frequently than advanced-stage patients (61.8% vs. 74.6%, p = 0.028), as reported in Table 2.
Our unadjusted models indicated that the patients with no knowledge of cervical cancer symptoms and risks had higher odds of advanced-stage cervical cancer at presentation (OR = 2.00, 95% CI: 1.18–3.40, p = 0.010). Patients who reported cooking outside or in a building separate from the house were 82.0% more likely to have advanced-stage cancer than those who reported cooking in their house (p = 0.029). In the final adjusted model, after adjusting by education, residence, the place the participants cooked, and place where they stayed when they received treatment, the only variable associated with higher odds of advanced-stage cervical cancer at presentation (OR = 1.87, 95% CI: 1.09–3.23, p = 0.023) was knowledge of cervical cancer symptoms and risks. Indicators of stable housing, such as cooking inside the home, was significantly associated with advanced-stage cervical cancer in the unadjusted model but not in the adjusted model (Table 3).
DISCUSSION
In this cross-sectional study of women with cervical cancer presenting to the Cancer Diseases Hospital in Lusaka, Zambia, we examined the relationship between SDOH and cancer stage at diagnosis. Nearly half of the participants were diagnosed with advanced-stage disease (FIGO stage III/IV). More than 60% of patients reported lacking prior knowledge about cervical cancer risks and symptoms, and this was the only factor significantly associated with advanced-stage presentation in the adjusted model. These findings underscore the critical role of awareness and health literacy in influencing timely care-seeking behavior.
Our results are consistent with those of Lombe et al. (2023), who applied the Three Delays Framework to cancer care in sub-Saharan Africa. Their systematic review identified that delays in seeking, reaching, and receiving quality care are often driven by interconnected barriers, with lack of awareness and low health literacy being dominant contributors to delayed care. Of note, our study primarily captured SDOH factors related to seeking and reaching treatment. Although our survey did not assess system-level barriers, our findings suggest that even women with higher education or urban residence may experience late-stage diagnosis due to uniformly low screening rates and limited access to early detection services. Notably, only 39% of participants reported having undergone cervical cancer screening prior to diagnosis.
In our cohort, none of the standard SDOH domains—including education level, housing stability, transportation access, and rurality—were significantly associated with advanced-stage diagnosis in adjusted models. The strong association between lack of knowledge and advanced-stage disease suggests that informational and behavioral factors may play a more immediate role than structural SDOH in this context. Our results may also be explained by Lombe et al.’s observation that low health literacy, fear, and reliance on traditional medicine are key contributors to delays in seeking care.^22^
Our findings on cervical cancer awareness align with those of previous studies conducted in Zambia and other LMICs. Although cervical cancer screening is freely available in Zambia, coverage remains low. For example, data from the 2021 Zambia Population-Based HIV Impact Assessment survey showed that only 22.2% of women aged 35–49 had undergone cervical cancer screening.^23^ Similarly to our study, Nyambe et al. (2019) reported that only 36.8% of participants (including women and men) were aware of cervical cancer symptoms, and just 38.8% of women in our cohort had undergone screening.^24^ Additionally, lack of awareness has been cited as the primary reason for not undergoing screening.^25,26^ Importantly, while all women are at risk of cervical cancer, women living with HIV (WLHIV) face a significantly higher risk—approximately six times greater than that of HIV-negative women.^27,28^ A study by Mukosha et al. found that HIV status impacts cervical cancer awareness and screening rates; among WLHIV in Lusaka, 62.4% were aware of cervical cancer screening, and 36.5% had been screened, suggesting that WLHIV may be more informed and proactive about screening.^29^ Although WLWH in our cohort demonstrated higher levels of knowledge, this did not translate into earlier presentation; they remained equally likely to be diagnosed at a late stage.
The strengths of our study include its cross-sectional design, the use of a validated survey instrument to assess multiple SDOH domains (e.g., education, transportation, housing, and utility needs), translation of the survey into multiple local languages, and engagement of local staff at CDH, the only cancer hospital in Zambia. Limitations include the relatively small cohort size, which may have limited our power to detect moderate effects in multivariable analyses. Additionally, our sample only included patients who presented to CDH with a cervical cancer diagnosis, which may not be representative of all women living with cervical cancer in Zambia.^23^ Selection bias may have been introduced, as enrollment was conducted during clinical visits and limited to women who spoke one of the four most common languages in Zambia. Finally, recall and reporting bias may have affected survey responses.
CONCLUSION
Lack of knowledge about the risk and symptoms of cervical cancer was significantly associated with advanced FIGO stage (III/IV) at presentation of cervical cancer among patients in Zambia even after adjusting for other SDOH domains. As described in Lombe et al., future studies are needed to evaluate the interaction between system-level barriers—such as misdiagnosis, poor referral coordination, and limited infrastructure and individual level determinants. Furthermore, additional studies are needed to identify population-based educational interventions as well as interventions focused on increasing screening rates in the general population to improve cervical cancer outcomes in Zambia.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Social determinants of health. Accessed July 13, 2025. https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1
- 2Askari A, Nachiappan S, Currie A, The relationship between ethnicity, social deprivation and late presentation of colorectal cancer. Cancer Epidemiol. 2017;47:88–93. doi:10.1016/j.canep.2017.01.00728167416 · doi ↗ · pubmed ↗
- 3Daniell JR, Dolja-Gore X, Mc Dowell L, The impact of travel distance to treatment centre on oral tongue squamous cell carcinoma survival and recurrence. Int J Oral Maxillofac Surg. 2022;51(7):854–861. doi:10.1016/j.ijom.2021.08.02634551874 · doi ↗ · pubmed ↗
- 4Han L, Sullivan R, Tree A, The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: A national population-based evaluation. Radiotherapy and Oncology. 2024;192. doi:10.1016/j.radonc.2024.110092 · doi ↗
- 5Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021;21(1). doi:10.1186/S 12889-021-10907-5, · doi ↗
- 6de Oliveira NPD, de Camargo Cancela M, Martins LFL, de Souza DLB. A multilevel assessment of the social determinants associated with the late stage diagnosis of breast cancer. Sci Rep. 2021;11(1):1–9. doi:10.1038/S 41598-021-82047-0;SUBJMETA=1347,2195,2324,631,67;KWRD=BREAST+CANCER,CANCER,CANCER+EPIDEMIOLOGY,CANCER+PREVENTION 33414495 PMC 7791137 · doi ↗ · pubmed ↗
- 7Ssemata AS, Muhumuza R, Seeley J, Moving forward through consensus: a national Delphi approach to determine the top research priorities in prostate cancer in Uganda. BMJ Open. 2023;13(11):e 075739. doi:10.1136/BMJOPEN-2023-075739 · doi ↗
- 8Tekalign T, Teshome M. Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis. P Lo S One. 2022;17(4 April). doi:10.1371/JOURNAL.PONE.0267571, · doi ↗
